United States - English - NLM (National Library of Medicine)

shionogi inc. - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine 8.5 mg - sular is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. sular is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.

United States - English - NLM (National Library of Medicine)

united research laboratories, inc. - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine 8.5 mg - nisoldipine is indicated for the treatment of hypertension. it maybe used alone or in combination with other antihypertensive agents. nisoldipine is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.

Singapore - English - HSA (Health Sciences Authority)

mundipharma pharmaceuticals pte. ltd. - prednisone - tablet, delayed release - 1.00mg/tablet

Singapore - English - HSA (Health Sciences Authority)

mundipharma pharmaceuticals pte. ltd. - prednisone - tablet, delayed release - 2.00mg/tablet

Singapore - English - HSA (Health Sciences Authority)

mundipharma pharmaceuticals pte. ltd. - prednisone - tablet, delayed release - 5.00mg/tablet

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine 25.5 mg - sular is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. sular is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.

United States - English - NLM (National Library of Medicine)

casper pharma llc - fenofibrate (unii: u202363uos) (fenofibric acid - unii:bgf9mn2hu1) - fenofibrate 160 mg - triglide is indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (ldl-c), total cholesterol (total-c), triglycerides, and apolipoprotein b (apo b), and to increase high-density lipoprotein cholesterol (hdl-c) in adult patients with primary hypercholesterolemia or mixed dyslipidemia. triglide is also indicated as adjunctive therapy to diet for treatment of adult patients with severe hypertriglyceridemia. improving glycemic control in diabetic patients showing fasting chylomicronemia will usually reduce fasting triglycerides and eliminate chylomicronemia thereby obviating the need for pharmacologic intervention. markedly elevated levels of serum triglycerides (e.g., >2,000 mg/dl) may increase the risk of developing pancreatitis. the effect of fenofibrate therapy on reducing this risk has not been adequately studied. fenofibrate was not shown to reduce coronary heart disease morbidity and mortality in a large, randomized controlled trial of patients with type 2 diabetes

United States - English - NLM (National Library of Medicine)

shionogi inc. - fenofibrate (unii: u202363uos) (fenofibrate - unii:u202363uos) - fenofibrate 160 mg - triglide is indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (ldl-c), total cholesterol (total-c), triglycerides, and apolipoprotein b (apo b), and to increase high-density lipoprotein cholesterol (hdl-c) in adult patients with primary hypercholesterolemia or mixed dyslipidemia. triglide is also indicated as adjunctive therapy to diet for treatment of adult patients with severe hypertriglyceridemia. improving glycemic control in diabetic patients showing fasting chylomicronemia will usually reduce fasting triglycerides and eliminate chylomicronemia thereby obviating the need for pharmacologic intervention. markedly elevated levels of serum triglycerides (e.g., >2,000 mg/dl) may increase the risk of developing pancreatitis. the effect of fenofibrate therapy on reducing this risk has not been adequately studied. fenofibrate was not shown to reduce coronary heart disease morbidity and mortality in a large, randomized controlled trial of patients with type 2 diabetes

United States - English - NLM (National Library of Medicine)

key therapeutics, llc - fenofibrate (unii: u202363uos) (fenofibric acid - unii:bgf9mn2hu1) - fenofibrate 160 mg

United States - English - NLM (National Library of Medicine)

alembic labs llc - bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u) - bisoprolol fumarate   is indicated in the management of hypertension. it may be used alone or in combination with other antihypertensive agents. bisoprolol fumarate  is contraindicated in patients with cardiogenic shock, overt cardiac failure, second or third degree av block, and marked sinus bradycardia.